Medicinal Products Reimbursement

Dáil Éireann Debate, Tuesday - 27 June 2017

Tuesday, 27 June 2017

Ceisteanna (396)

John Curran

Ceist:

396. Deputy John Curran asked the Minister for Health the position regarding the review being undertaken by his Department and the HSE following the decision of the NCPE in December 2016 to recommend against funding Respreeza; if the HSE or NCPE has met with a company (details supplied); if they reviewed the evidence presented in a second study published in a publication (details supplied); and if he will make a statement on the matter. [29930/17]

Freagraí scríofa

Minister for Health

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.

Question No. 397 answered with Question No. 392.

Question No. 398 answered with Question No. 379.